Topical administration of the secretome derived from human amniotic epithelial cells ameliorates psoriasis-like skin lesions in mice

Abstract Background Psoriasis is a chronic inflammatory skin disease. Tissue stem cells have exhibited a therapeutic effect on psoriatic mice. However, the therapeutic effect of topical administration of the secretome derived from tissue stem cells on psoriasis has not been reported. Methods The sec...

Full description

Bibliographic Details
Main Authors: Mengbo Yang, Lanqi Wang, Zhimin Chen, Weijie Hao, Qian You, Jianhua Lin, Jingzhi Tang, Xin Zhao, Wei-Qiang Gao, Huiming Xu
Format: Article
Language:English
Published: BMC 2022-08-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:https://doi.org/10.1186/s13287-022-03091-9
_version_ 1811315279216508928
author Mengbo Yang
Lanqi Wang
Zhimin Chen
Weijie Hao
Qian You
Jianhua Lin
Jingzhi Tang
Xin Zhao
Wei-Qiang Gao
Huiming Xu
author_facet Mengbo Yang
Lanqi Wang
Zhimin Chen
Weijie Hao
Qian You
Jianhua Lin
Jingzhi Tang
Xin Zhao
Wei-Qiang Gao
Huiming Xu
author_sort Mengbo Yang
collection DOAJ
description Abstract Background Psoriasis is a chronic inflammatory skin disease. Tissue stem cells have exhibited a therapeutic effect on psoriatic mice. However, the therapeutic effect of topical administration of the secretome derived from tissue stem cells on psoriasis has not been reported. Methods The secretome from human amniotic epithelial cells (AEC-SC) and human umbilical cord mesenchymal stem cells (UMSC-SC) was topically administrated on the back of imiquimod-induced psoriasis-like mice. Subsequently, we observed the skin lesions and skin inflammation of psoriasis-like mice. Next, we further analyzed the paracrine factors in AEC-SC and UMSC-SC by protein chips. Lastly, the effect of the crucial paracrine factor was investigated by imiquimod-induced psoriasis-like mice. Results We found that AEC-SC had a better therapeutic effect on attenuating psoriasis-like skin lesions including skin scales, skin redness and skin thickness than UMSC-SC, and it had a better regulatory effect on keratinocyte hyperproliferation and altered differentiation. Thus, we focused on AEC-SC. Further study showed that AEC-SC reduced the infiltration of neutrophils and interleukin-17-producing T cells. Next, the analysis of AEC-SC with protein chip revealed that the levels of anti-inflammatory factor interleukin-1 receptor antagonist (IL-1ra) were much higher in AEC-SC compared to that in UMSC-SC. More importantly, the beneficial effect of AEC-SC on psoriasis-like skin lesions and skin inflammation of mice were significantly impaired when neutralizing with IL-1ra antibody, while the recombinant human IL-1ra showed a less protective effect than AEC-SC. Conclusions The present study demonstrated that AEC-SC could efficiently ameliorate psoriasis-like skin lesions and skin inflammation and IL-1ra plays an essential role. Therefore, topical administration of AEC-SC may provide a novel strategy for treating psoriasis-like inflammatory skin diseases.
first_indexed 2024-04-13T11:28:31Z
format Article
id doaj.art-4b827f112f4642fe96704c783f3c650b
institution Directory Open Access Journal
issn 1757-6512
language English
last_indexed 2024-04-13T11:28:31Z
publishDate 2022-08-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj.art-4b827f112f4642fe96704c783f3c650b2022-12-22T02:48:38ZengBMCStem Cell Research & Therapy1757-65122022-08-0113111410.1186/s13287-022-03091-9Topical administration of the secretome derived from human amniotic epithelial cells ameliorates psoriasis-like skin lesions in miceMengbo Yang0Lanqi Wang1Zhimin Chen2Weijie Hao3Qian You4Jianhua Lin5Jingzhi Tang6Xin Zhao7Wei-Qiang Gao8Huiming Xu9State Key Laboratory of Oncogenes and Related Genes, Renji-MedX Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Dermatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong UniversityState Key Laboratory of Oncogenes and Related Genes, Renji-MedX Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong UniversityState Key Laboratory of Oncogenes and Related Genes, Renji-MedX Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong UniversityState Key Laboratory of Oncogenes and Related Genes, Renji-MedX Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Obstetrics and Gynecology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong UniversityState Key Laboratory of Oncogenes and Related Genes, Renji-MedX Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Dermatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong UniversityState Key Laboratory of Oncogenes and Related Genes, Renji-MedX Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong UniversityState Key Laboratory of Oncogenes and Related Genes, Renji-MedX Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong UniversityAbstract Background Psoriasis is a chronic inflammatory skin disease. Tissue stem cells have exhibited a therapeutic effect on psoriatic mice. However, the therapeutic effect of topical administration of the secretome derived from tissue stem cells on psoriasis has not been reported. Methods The secretome from human amniotic epithelial cells (AEC-SC) and human umbilical cord mesenchymal stem cells (UMSC-SC) was topically administrated on the back of imiquimod-induced psoriasis-like mice. Subsequently, we observed the skin lesions and skin inflammation of psoriasis-like mice. Next, we further analyzed the paracrine factors in AEC-SC and UMSC-SC by protein chips. Lastly, the effect of the crucial paracrine factor was investigated by imiquimod-induced psoriasis-like mice. Results We found that AEC-SC had a better therapeutic effect on attenuating psoriasis-like skin lesions including skin scales, skin redness and skin thickness than UMSC-SC, and it had a better regulatory effect on keratinocyte hyperproliferation and altered differentiation. Thus, we focused on AEC-SC. Further study showed that AEC-SC reduced the infiltration of neutrophils and interleukin-17-producing T cells. Next, the analysis of AEC-SC with protein chip revealed that the levels of anti-inflammatory factor interleukin-1 receptor antagonist (IL-1ra) were much higher in AEC-SC compared to that in UMSC-SC. More importantly, the beneficial effect of AEC-SC on psoriasis-like skin lesions and skin inflammation of mice were significantly impaired when neutralizing with IL-1ra antibody, while the recombinant human IL-1ra showed a less protective effect than AEC-SC. Conclusions The present study demonstrated that AEC-SC could efficiently ameliorate psoriasis-like skin lesions and skin inflammation and IL-1ra plays an essential role. Therefore, topical administration of AEC-SC may provide a novel strategy for treating psoriasis-like inflammatory skin diseases.https://doi.org/10.1186/s13287-022-03091-9PsoriasisAEC-SCSkin lesionsSkin inflammationIL-1ra
spellingShingle Mengbo Yang
Lanqi Wang
Zhimin Chen
Weijie Hao
Qian You
Jianhua Lin
Jingzhi Tang
Xin Zhao
Wei-Qiang Gao
Huiming Xu
Topical administration of the secretome derived from human amniotic epithelial cells ameliorates psoriasis-like skin lesions in mice
Stem Cell Research & Therapy
Psoriasis
AEC-SC
Skin lesions
Skin inflammation
IL-1ra
title Topical administration of the secretome derived from human amniotic epithelial cells ameliorates psoriasis-like skin lesions in mice
title_full Topical administration of the secretome derived from human amniotic epithelial cells ameliorates psoriasis-like skin lesions in mice
title_fullStr Topical administration of the secretome derived from human amniotic epithelial cells ameliorates psoriasis-like skin lesions in mice
title_full_unstemmed Topical administration of the secretome derived from human amniotic epithelial cells ameliorates psoriasis-like skin lesions in mice
title_short Topical administration of the secretome derived from human amniotic epithelial cells ameliorates psoriasis-like skin lesions in mice
title_sort topical administration of the secretome derived from human amniotic epithelial cells ameliorates psoriasis like skin lesions in mice
topic Psoriasis
AEC-SC
Skin lesions
Skin inflammation
IL-1ra
url https://doi.org/10.1186/s13287-022-03091-9
work_keys_str_mv AT mengboyang topicaladministrationofthesecretomederivedfromhumanamnioticepithelialcellsamelioratespsoriasislikeskinlesionsinmice
AT lanqiwang topicaladministrationofthesecretomederivedfromhumanamnioticepithelialcellsamelioratespsoriasislikeskinlesionsinmice
AT zhiminchen topicaladministrationofthesecretomederivedfromhumanamnioticepithelialcellsamelioratespsoriasislikeskinlesionsinmice
AT weijiehao topicaladministrationofthesecretomederivedfromhumanamnioticepithelialcellsamelioratespsoriasislikeskinlesionsinmice
AT qianyou topicaladministrationofthesecretomederivedfromhumanamnioticepithelialcellsamelioratespsoriasislikeskinlesionsinmice
AT jianhualin topicaladministrationofthesecretomederivedfromhumanamnioticepithelialcellsamelioratespsoriasislikeskinlesionsinmice
AT jingzhitang topicaladministrationofthesecretomederivedfromhumanamnioticepithelialcellsamelioratespsoriasislikeskinlesionsinmice
AT xinzhao topicaladministrationofthesecretomederivedfromhumanamnioticepithelialcellsamelioratespsoriasislikeskinlesionsinmice
AT weiqianggao topicaladministrationofthesecretomederivedfromhumanamnioticepithelialcellsamelioratespsoriasislikeskinlesionsinmice
AT huimingxu topicaladministrationofthesecretomederivedfromhumanamnioticepithelialcellsamelioratespsoriasislikeskinlesionsinmice